Is protease inhibitor a choice for the treatment of pre- or mild disseminated intravascular coagulation?

Abstract

In a limited number of patients (n = 34), gabexate mesylate (2 mg/kg/hr) could not inhibit coagulation or fibrinolysis and gabexate mesylate could not improve the DIC score or mortality rate in pre- or mild DIC.